斯佩克辛是调节莱普敏感性的过程中的生物标志物
Mohamed Badie Ahmed1, Abdella M Habib2, Saif Badran3
1Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar; Plastic Surgery Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Peptides
|May 26, 2025
概括
肥胖是一个全球性的健康威胁. 这项研究发现,像GLP-1和GIP这样的肠道激素会影响瘦素敏感性,而spexin可能会作为肥胖患者这一关键代谢相互作用的生物标志物.
科学领域:
- 代谢研究的研究.
- 内分泌学 在内分泌学.
- 肥胖研究的研究.
背景情况:
- 全球肥胖率的上升需要了解潜在的机制.
- 瘦素耐药性是肥胖病原发生的一个关键因素.
- 肠道激素在新陈代谢调节中发挥作用.
研究的目的:
- 为了研究肥胖,瘦素敏感性和特定肠道激素之间的关系:spexin,葡萄糖类-1 (GLP-1) 和胃抑制性多 (GIP).
- 评估勒普丁和这些肠道激素在接受身体轮手术的个体之间的相互作用.
主要方法:
- 来自接受身体轮手术的患者的血液样本的分析.
- 在三个不同的时间点测量激素水平 (spexin,GLP-1,GIP,勒).
- 激素水平与瘦素敏感性指标之间的相关性分析.
主要成果:
- 增加的葡萄糖类-1 (GLP-1) 和降低的胃抑制性多 (GIP) 水平与改善的勒敏度有关.
- 通过降低血瘦素水平,改善了瘦素敏感性.
- 一个更的血瘦素-spexin斜坡与改善的瘦素敏感性相关.
结论:
- 肠道激素,特别是GLP-1和GIP,调节肥胖个体的瘦素敏感性.
- 斯佩克辛可以作为丁敏感性的潜在生物标志物.
- 通过肠道激素调节准瘦素敏感性为肥胖管理提供了一个潜在的策略.
相关概念视频
Cell Specific Gene Expression
13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
Regulation of Food Intake
204
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
204
Spare Receptors
3.5K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
3.5K
Glucagon-like Receptor Agonists
306
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
306


